Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Illumina (ILMN – Research Report), Palatin Technologies (PTN – Research Report) and Medtronic (MDT – Research Report).
Illumina (ILMN)
In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Illumina, with a price target of $190.00. The company’s shares closed last Friday at $127.10.
According to TipRanks.com, Westenberg is a 3-star analyst with an average return of
Currently, the analyst consensus on Illumina is a Moderate Buy with an average price target of $143.21, representing a 7.1% upside. In a report issued on December 12, Wolfe Research also initiated coverage with a Buy rating on the stock with a $175.00 price target.
See today’s best-performing stocks on TipRanks >>
Palatin Technologies (PTN)
Ladenburg Thalmann & Co. analyst Michael Higgins maintained a Buy rating on Palatin Technologies today and set a price target of $50.00. The company’s shares closed last Friday at $2.65.
According to TipRanks.com, Higgins is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Palatin Technologies with a $60.00 average price target.
Medtronic (MDT)
Piper Sandler analyst Matthew O’Brien maintained a Hold rating on Medtronic today and set a price target of $87.00. The company’s shares closed last Friday at $82.61.
According to TipRanks.com, O’Brien is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Medtronic with a $88.20 average price target, representing a 6.2% upside. In a report issued on December 11, Citi also maintained a Hold rating on the stock with a $86.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ILMN:
- Illumina (NASDAQ:ILMN) Divests Grail Following Years-Long Antitrust Battle
- Court sides with FTC finding Illumina-Grail deal anticompetitive, WSJ reports
- GE upgraded, Northrop Grumman downgraded: Wall Street’s top analyst calls
- Illumina just upgraded at Bernstein, here’s why
- Illumina upgraded to Market Perform from Underperform at Bernstein
